Studies | EBMT

Top

Study type

Disease

Group

Type of transplant / Cell therapy

Text

Language

Use of regulatory T cells for GvHD prophylaxis and therapy in Europe

Closed Survey/Study

Cellular Therapy & Immunobiology Working Party (CTIWP)

Type of treatment

Principal investigator

Federico Simonetta

LA-DP Immunopeptidome Divergence Predicts CD4⁺ T-Cell Alloreactivity and Outcome of Hematopoietic Cell Transplantation

Retrospective Studies

Acute Myeloid Leukaemia (AML)

Acute Lymphatic Leukaemia (ALL)

Myelodysplastic (MDS) or MDS/MPN

Cellular Therapy & Immunobiology Working Party (CTIWP)

Type of treatment

Principal investigator

Peter van Balen & Liesbeth de Wreede

Real-World Use of Post-Transplant Cyclophosphamide (PTCy) for Graft-Vs-Host-Disease (GVHD) Prophylaxis in Transplant Centers

Closed Survey/Study

Cellular Therapy & Immunobiology Working Party (CTIWP)

Type of treatment

Principal investigator

Outcomes of patients over 70 years treated with brexucabtagene autoleucel for relapsed refractory mantle cell lymphoma: a study from the CTIWP of EBMT

Retrospective Studies

Other myeloid or lymphoid malignancies

Cellular Therapy & Immunobiology Working Party (CTIWP)

Type of treatment

Principal investigator

Characteristics and outcomes of extramedullary myeloma receiving CAR-T cell therapy

Retrospective Studies

Multiple Myeloma (MM) or other Plasma Cell Disorder (PCD)

Chronic Malignancies Working Party (CMWP)

Cellular Therapy & Immunobiology Working Party (CTIWP)

Type of treatment

Principal investigator

Tomas Jelinek/Nico Gagelmann

Nutritional Care Practices during CAR-T Cell Treatment in Adult Patients

Closed Survey/Study

Nursing Research Committee

Cellular Therapy & Immunobiology Working Party (CTIWP)

Type of treatment

Principal investigator

Paolo Pedrazzoli

Outcomes after anti-BCMA CAR T-cells for multiple myeloma, a Retrospective analysis on behalf of the CTIWP and CMWP of the EBMT

Retrospective Studies

Multiple Myeloma (MM) or other Plasma Cell Disorder (PCD)

Cellular Therapy & Immunobiology Working Party (CTIWP)

Chronic Malignancies Working Party (CMWP)

Type of treatment

Principal investigator

IDWP-CTIWP: Survey on vaccination strategy in CAR-T patients

Closed Survey/Study

Infectious Diseases Working Party (IDWP)

Cellular Therapy & Immunobiology Working Party (CTIWP)

Type of treatment

Principal investigator

Agnieszka Piekarska

Survey on fertility procedures and outcomes for patients treated with CAR-T cell therapy

Closed Survey/Study

Cellular Therapy & Immunobiology Working Party (CTIWP)

Type of treatment

Principal investigator

Giorgio Orofino

CAR-T in elderly patients

Retrospective Studies

Non-Hodgkin’s Lymphoma (NHL)

Cellular Therapy & Immunobiology Working Party (CTIWP)

Type of treatment

Principal investigator

Vanderson Rocha

Disease-specificity effects of HLA mismatching effects in unrelated HCT under with PTCy-based GvHD prophylaxis

Retrospective Studies

Acute Lymphatic Leukaemia (ALL)

Acute Myeloid Leukaemia (AML)

Chronic Lymphocytic Leukaemia (CLL)

Chronic Myeloid Lymphoma (CML)

Chronic Lymphocytic Leukaemia (CLL)

Myelodysplastic (MDS) or MDS/MPN

Other myeloid or lymphoid malignancies

Multiple Myeloma (MM) or other Plasma Cell Disorder (PCD)

Non-Hodgkin’s Lymphoma (NHL)

Cellular Therapy & Immunobiology Working Party (CTIWP)

Acute Leukemia Working Party (ALWP)

Type of treatment

Allogeneic - Unrelated

Principal investigator

HLA Mismatch Frequencies in Unrelated Hematopoietic Cell Transplantation

Retrospective Studies

Cellular Therapy & Immunobiology Working Party (CTIWP)

Type of treatment

Allogeneic - Unrelated

Principal investigator

Esteban Arrieta Bolaños